New ‘Cicada’ COVID Variant Spreading in the U.S.: Symptoms, Origins, and What You Need to Know (March 2026)
As the United States enters the spring of 2026, health officials have identified a new strain of the virus: the ‘Cicada’ COVID variant. Emerging rapidly across several states, this subvariant—scientifically labeled as XBB.1.26.4—has earned its nickname due to its sudden "emergence" and unique genetic markers. But how dangerous is it, and should you be worried?
What is the Cicada Variant? Unlike previous mutations, the Cicada COVID variant symptoms appear to lean more toward upper respiratory inflammation. Early data suggests it is highly evasive of previous immunity, meaning even those vaccinated or previously infected in 2025 may be at risk. According to recent reports, the variant was first detected in the Pacific Northwest but has since migrated to the East Coast.
Current Symptoms to Watch For: While much remains the same, doctors are noting a few distinct "Cicada" traits:
Persistent Dry Cough: More intense than the common cold.
Severe Ear Pressure: A new symptom being reported by patients in the U.S.
Extreme Fatigue: Often lasting 3-5 days before other symptoms appear.
Loss of Taste/Smell: While rare in Omicron, it is seeing a slight resurgence with this strain.
Is it More Dangerous? Current hospitalizations remain stable, but the Cicada variant spread is being monitored closely by the CDC. Experts suggest that while it is more transmissible, the severity does not yet match the original Delta strain. However, for those with underlying conditions, staying updated with the latest 2026 boosters is essential.
Conclusion: The "Cicada" variant is a reminder that the virus continues to adapt. Staying informed through 360-degree reporting is your best defense. For more updates on the U.S. health landscape, stay tuned to UK News 360 View.
According to a detailed breakdown by
This news comes as the BBC recently updated its health policies following the
